4.6 Review

Phosphodiesterase 4B: Master Regulator of Brain Signaling

Journal

CELLS
Volume 9, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/cells9051254

Keywords

phosphodiesterase; cyclic-AMP; rolipram; PDE4B; neuroinflammation

Categories

Funding

  1. College of Medical, Veterinary and Life Sciences, University of Glasgow
  2. BHF [PG/17/26/32881]

Ask authors/readers for more resources

Phosphodiesterases (PDEs) are the only superfamily of enzymes that have the ability to break down cyclic nucleotides and, as such, they have a pivotal role in neurological disease and brain development. PDEs have a modular structure that allows targeting of individual isoforms to discrete brain locations and it is often the location of a PDE that shapes its cellular function. Many of the eleven different families of PDEs have been associated with specific diseases. However, we evaluate the evidence, which suggests the activity from a sub-family of the PDE4 family, namely PDE4B, underpins a range of important functions in the brain that positions the PDE4B enzymes as a therapeutic target for a diverse collection of indications, such as, schizophrenia, neuroinflammation, and cognitive function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available